Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita

This study has been terminated.
(Study was terminated due to under enrollment)
Sponsor:
Information provided by (Responsible Party):
Colin Sieff, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01001598
First received: October 22, 2009
Last updated: September 12, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)